Ikena Oncology Inc expected to post a loss of 27 cents a share - Earnings Preview

ImageneBio

06/11/2024 14:16

* Ikena Oncology Inc  IKNA.OQ   IKNA.O  is expected to show
a fall
in quarterly revenue when it reports  results on November 7
(estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Ikena Oncology Inc is
for a
loss of 27 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Ikena
Oncology
Inc is $4.00​, above​ its last closing price of $1.69. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.33       -0.35      -0.28     Beat    19.4
 Mar. 31 2024  -0.41       -0.41      -0.33     Beat    20
 Dec. 31 2023              -0.43      -0.47     Missed  -9.8​
 Sep. 30 2023  -0.42       -0.43      -0.40     Beat    7
 ​​Jun.        -0.46       -0.47      -0.44     Beat    7.3
 30 2023                                                
 Mar. 31 2023  -0.47       -0.47      -0.39     Beat    16.6​
 Dec. 31 2022  -0.53       -0.48      -0.40     Beat    16.1
 Sep. 30 2022  -0.48       -0.50      -0.48     Beat    3.1
 This summary was machine generated November 6 at 14:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)